193 related articles for article (PubMed ID: 27531892)
21. Single Nucleotide Polymorphisms in
Bei C; Liu S; Yu X; Qiu M; Tang B; Liao W; He S; Yu H
Biomed Res Int; 2018; 2018():1540201. PubMed ID: 30662901
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-224 Expression and Polymorphism Predict the Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients After Liver Resection.
Wu C; Wang X; Zhang J; Tang G; Xu Y; Lu C; Li Y
Clin Lab; 2019 Jun; 65(6):. PubMed ID: 31232017
[TBL] [Abstract][Full Text] [Related]
23. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
Lu M; Kong X; Wang H; Huang G; Ye C; He Z
Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
[TBL] [Abstract][Full Text] [Related]
24. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
25. Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma.
Cheong JY; Shin HD; Cho SW; Kim YJ
J Korean Med Sci; 2014 Nov; 29(11):1523-7. PubMed ID: 25408584
[TBL] [Abstract][Full Text] [Related]
26. Identification of miR-423 and miR-499 polymorphisms on affecting the risk of hepatocellular carcinoma in a large-scale population.
Ma Y; Wang R; Zhang J; Li W; Gao C; Liu J; Wang J
Genet Test Mol Biomarkers; 2014 Jul; 18(7):516-24. PubMed ID: 24854593
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7.
Yang W; Dou C; Wang Y; Jia Y; Li C; Zheng X; Tu K
Oncol Rep; 2015 Nov; 34(5):2576-84. PubMed ID: 26323375
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma.
Xu Q; Zhang M; Tu J; Pang L; Cai W; Liu X
Oncol Rep; 2015 Oct; 34(4):2054-64. PubMed ID: 26252254
[TBL] [Abstract][Full Text] [Related]
29. Association between an insertion/deletion polymorphism within 3'UTR of SGSM3 and risk of hepatocellular carcinoma.
Wang C; Zhao H; Zhao X; Wan J; Wang D; Bi W; Jiang X; Gao Y
Tumour Biol; 2014 Jan; 35(1):295-301. PubMed ID: 23918301
[TBL] [Abstract][Full Text] [Related]
30. An indel polymorphism within pre-miR3131 confers risk for hepatocellular carcinoma.
Wang C; Li L; Yin Z; Zhang Q; Zhao H; Tao R; Wang S; Hu S; He Y; Wang D; Li C; Zhang S; Xu J; Jiang X; Zhu S; Gao Y
Carcinogenesis; 2017 Feb; 38(2):168-176. PubMed ID: 28034876
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-936 Targets JAG1 and Inhibits the Proliferation of Hepatocellular Carcinoma Cells.
Tian J; Zhao Y; Li L; Cui Y; Wu Y
Technol Cancer Res Treat; 2021; 20():1533033820985785. PubMed ID: 33550933
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms in the precursor microRNAs and aflatoxin B1-related hepatocellular carcinoma.
Long XD; Huang XY; Yao JG; Liao P; Tang YJ; Ma Y; Xia Q
Mol Carcinog; 2016 Jun; 55(6):1060-72. PubMed ID: 26152337
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor.
Wang K; Liang Q; Wei L; Zhang W; Zhu P
Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
Cai L; Cai X
Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
[TBL] [Abstract][Full Text] [Related]
36. High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma.
Wang WY; Zhang HF; Wang L; Ma YP; Gao F; Zhang SJ; Wang LC
Diagn Pathol; 2014 Aug; 9():160. PubMed ID: 25123453
[TBL] [Abstract][Full Text] [Related]
37. MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma.
Ma XP; Yu G; Chen X; Xiao Q; Shi Z; Zhang LY; Chen H; Zhang P; Ding DL; Huang HX; Saiyin H; Chen TY; Lu PX; Wang NJ; Yu H; Conran C; Sun J; Zheng SL; Xu J; Yu L; Jiang DK
Tumour Biol; 2016 Jul; 37(7):9931-42. PubMed ID: 26815502
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
[TBL] [Abstract][Full Text] [Related]
39. A Single-Nucleotide Polymorphism of miR-196a2T>C rs11614913 Is Associated with Hepatocellular Carcinoma in the Chinese Population.
Li J; Cheng G; Wang S
Genet Test Mol Biomarkers; 2016 Apr; 20(4):213-5. PubMed ID: 26866381
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-769-5p contributes to the proliferation, migration and invasion of hepatocellular carcinoma cells by attenuating RYBP.
Xian Y; Wang L; Yao B; Yang W; Mo H; Zhang L; Tu K
Biomed Pharmacother; 2019 Oct; 118():109343. PubMed ID: 31545279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]